default author photo

Meletios A. Dimopoulos

National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit

Athens

Greece

  • National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit

SCHOLARLY PAPERS

8

DOWNLOADS

447

TOTAL CITATIONS

3

Scholarly Papers (8)

Actions:
Email selected abstracts
1.

Oncological Patients with Endocrine Complications after Immunotherapy with Checkpoint Inhibitors Present Longer Progression Free and Overall Survival

Number of pages: 25 Posted: 16 Dec 2021
Stavroula A. Paschou, Michael Liontos, Evangelos Eleftherakis-Papaiakovou, Katerina Stefanaki, Christos Markellos, Konstantinos Koutsoukos, Flora Zagouri, Theodora Psaltopoulou and Meletios A. Dimopoulos
National and Kapodistrian University of Athens Medical School - Endocrine Unit and Diabetes Center, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National and Kapodistrian University of Athens Medical School - Endocrine Unit and Diabetes Center, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit and National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit
Downloads 120 (596,393)

Abstract:

Loading...

ICIs immunotherapy, endocrine complications, progression free survival, overall survival, thyroiditis

2.

Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies

Number of pages: 47 Posted: 09 Feb 2022
Cristina Bergamaschi, Maria Pagoni, Margherita Rosati, Matthew Angel, Ifigeneia Tzannou, Margarita Vlachou, Ismini Darmani, Amirah Ullah, Jenifer Bear, Santhi Devasundaram, Robert Burns, Ioannis Baltadakis, Stavros Gigantes, Meletios A. Dimopoulos, George N. Pavlakis, Evangelos Terpos and Barbara K. Felber
National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, Evangelismos General Hospital of Athens - Hematology-Lymphomas Department - BMT Unit, National Cancer Institute at Frederick - Human Retrovirus Section, Government of the United States of America - Vaccine Branch, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, affiliation not provided to SSRN, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, affiliation not provided to SSRN, affiliation not provided to SSRN, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National Cancer Institute at Frederick - Human Retrovirus Section, National and Kapodistrian University of Athens - Department of Clinical Therapeutics and Government of the United States of America - Human Retrovirus Pathogenesis Section
Downloads 65 (924,743)

Abstract:

Loading...

humoral response, cytokine, SARS-CoV-2 BNT162b2 mRNA vaccine, IFN-gamma, CXCL10, IL-15

3.

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection

Number of pages: 36 Posted: 11 Oct 2021
Margherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Mahesh Agarwal, Jenifer Bear, Robert Burns, Xintao Hu, Eleni Korompoki, Duncan Donohue, David J. Venzon, Meletios A. Dimopoulos, George N. Pavlakis and Barbara K. Felber
National Cancer Institute at Frederick - Human Retrovirus Section, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, - Department of Clinical Therapeutics, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, - Department of Clinical Therapeutics, Frederick National Laboratory for Cancer Research - MS Applied Information and Management Sciences, National Cancer Institute - Biostatistics and Data Management Section, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National Cancer Institute at Frederick - Human Retrovirus Section and National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section
Downloads 63 (942,565)
Citation 1

Abstract:

Loading...

Durability, longevity, COVID-19, antibody, kinetics, SARS-CoV-2 variant, neutralization, anamnestic response, recall, re-exposure, Spike, Nucleocapsid, Spike-RBD, variants of concern, Alfa, Beta, Delta, Mu

4.

Nocebo-Prone Behavior Contributes to SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers

Number of pages: 36 Posted: 14 Sep 2021
Dimos D. Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, Evrydiki KravvaritiM, Eleni Korompoki, Maria Mylona, Pinelopi Vryttia, Georgia Papagiannopoulou, Eumorphia-Maria Delicha, Athanasios Dellis, Georgios Tsivgoulis, Meletios A. Dimopoulos, Martina Amanzio and Petros Sfikakis
- First Neurology Department, - First Neurology Department, Rigshospitalet Glostrup - Danish Headache Centre, - First Department of Propaedeutic and Internal Medicine, - Department of Clinical Therapeutics, - First Department of Propaedeutic and Internal Medicine, - Department of Clinical Therapeutics, - Second Department of Neurology, ASTAT Statistics in Clinical Research, - 2nd Department of Surgery, - Second Department of Neurology, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, University of Turin - Department of Psychology and - First Department of Propaedeutic and Internal Medicine
Downloads 51 (1,063,489)
Citation 1

Abstract:

Loading...

SARS-CoV-2, nocebo, vaccine hesitancy, healthcare workers, tolerability, adverse event

5.

Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results from the Real-World, Retrospective EMN23 Study

Number of pages: 63 Posted: 22 Dec 2023
Arnaud Jaccard, Frank Bridoux, Wilfried Roeloffzen, Monique Minnema, Rui Bergantim, Roman Hájek, Cristina João, M. Teresa Cibeira, Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, Paolo Milani, Meletios A. Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Hermine Agis, Blanca Gros, Aisha Asra, Valeria Magarotto, Giorgos Cheliotis, Giorgos Psarros, Pieter Sonneveld, Ashutosh Wechalekar and Efstathios Kastritis
University of Limoges - National Amyloidosis Center and Hematology Unit, CHU de Poitiers - Nephrology Unit, University of Groningen - Amyloidosis Centre of Expertise, Utrecht University - University Medical Center (Utrecht), Universidade do Porto - São João Hospital, University of Ostrava - Faculty of Medicine, Champalimaud Foundation - Champalimaud Center for the Unknown, Hospital Clinic of Barcelona - Department of Hematology, University of Pavia - Department of Molecular Medicine, Heidelberg University - Medical Department V, Amyloidosis Center Heidelberg, University of Pavia - Department of Molecular Medicine, University of Pavia - Department of Molecular Medicine, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, University College London - National Amyloidosis Centre, Heidelberg University - University Hospital Heidelberg, University of Vienna - Department of Internal Medicine I, Janssen-Cilag S.A., Johnson & Johnson - Janssen-Cilag, Johnson & Johnson - Janssen-Cilag, Health Data Specialists, Health Data Specialists, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), University College London - National Amyloidosis Centre and National and Kapodistrian University of Athens Medical School - Department of Therapeutics
Downloads 43 (1,145,425)

Abstract:

Loading...

AL Amyloidosis, Healthcare Resource Utilization (HCRU), health economics, cost-of-Illness, dialysis

6.

Dr. Raymond Alexanian:  Pioneering Contributions to Multiple Myeloma Research, Treatment, and the Concept of Curability

Number of pages: 14 Posted: 18 Jun 2024
Despina Fotiou and Meletios A. Dimopoulos
National and Kapodistrian University of Athens and National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit
Downloads 39 (1,209,354)

Abstract:

Loading...

multiple myeloma, curability, indolent multiple myeloma, melphalan-prednisone, autologous stem cell transplant, high-dose melphalan

7.

Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated With Effective Immune Response in BNT162b2 mRNA Vaccine Recipients

Number of pages: 47 Posted: 23 Apr 2021
Cristina Bergamaschi, Evangelos Terpos, Matthew Angel, Jenifer Bear, Margherita Rosati, Dimitris Stellas, Sevasti Karaliota, Filia Apostolakou, Tina Bagratuni, Dimitris Patseas, Sentiljana Gumeni, Ioannis P. Trougakos, Meletios A. Dimopoulos, Barbara K. Felber and George N. Pavlakis
National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National Cancer Institute - Vaccine Branch, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Section, "Aghia Sophia" Children's Hospital - Department of Clinical Biochemistry, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National and Kapodistrian University of Athens - Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens - Department of Cell Biology and Biophysics, National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section and National Cancer Institute at Frederick - Human Retrovirus Section
Downloads 35 (1,249,711)
Citation 1

Abstract:

Loading...

SARS-CoV-2, mRNA, vaccine, innate immunity, IL-15, IFN-γ, IP10/CXCL10, TNF-, IL-6, Spike-RBD antibody

8.

Outcomes of Newly Diagnosed Multiple Myeloma Patients Requiring Dialysis

Number of pages: 16 Posted: 06 Feb 2025
Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Erasmia Psimenou, Nikolaos Kanellias, Maria Roussou, Magdalini Migkou, Evangelos Eleftherakis-Papaiakovou, Angeliki Andrikopoulou, Stavroula Giannouli, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis and Meletios A. Dimopoulos
National and Kapodistrian University of Athens, National and Kapodistrian University of Athens, affiliation not provided to SSRN, National and Kapodistrian University of Athens, - Department of Clinical Therapeutics, National and Kapodistrian University of Athens, affiliation not provided to SSRN, National and Kapodistrian University of Athens, affiliation not provided to SSRN, National and Kapodistrian University of Athens, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, National and Kapodistrian University of Athens, National and Kapodistrian University of Athens - Department of Clinical Therapeutics, National and Kapodistrian University of Athens Medical School - Department of Therapeutics and National and Kapodistrian University of Athens Medical School - Hematology and Oncology Unit
Downloads 31 (1,318,317)

Abstract:

Loading...

MULTIPLE MYELOMA, dialysis-dependence, renal response, bortezomib-based treatment